ArticlePloS one2015

Development of a Drug-Response Modeling Framework to Identify Cell Line Derived Translational Biomarkers That Can Predict Treatment Outcome to Erlotinib or Sorafenib.

Bin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.